Mirae Asset Global Investments’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Sell
6,469
-556
-8% -$13.7K ﹤0.01% 1115
2026
Q1
$147K Buy
7,025
+481
+7% +$6.7K ﹤0.01% 1126
2025
Q4
$58K Buy
6,544
+2,243
+52% +$19.3K ﹤0.01% 1364
2025
Q3
$36.1K Buy
4,301
+114
+3% +$772 ﹤0.01% 1395
2025
Q2
$21.4K Buy
4,187
+454
+12% +$1.12K ﹤0.01% 1393
2025
Q1
$5.49K Buy
3,733
+153
+4% +$376 ﹤0.01% 1510
2024
Q4
$11.2K Sell
3,580
-295
-8% -$1.37K ﹤0.01% 1500
2024
Q3
$28.9K Buy
3,875
+685
+21% +$6.54K ﹤0.01% 1383
2024
Q2
$27.2K Sell
3,190
-25,774
-89% -$199K ﹤0.01% 1344
2024
Q1
$149K Buy
28,964
+7,128
+33% +$76.4K ﹤0.01% 2315
2023
Q4
$216K Buy
21,836
+468
+2% +$4.06K ﹤0.01% 2311
2023
Q3
$241K Buy
21,368
+79
+0.4% +$482 ﹤0.01% 2230
2023
Q2
$70.7K Sell
21,289
-176
-0.8% -$633 ﹤0.01% 2573
2023
Q1
$84.8K Sell
21,465
-56
-0.3% -$325 ﹤0.01% 2469
2022
Q4
$156K Buy
21,521
+2,231
+12% +$15.7K ﹤0.01% 2359
2022
Q3
$70K Buy
19,290
+5,950
+45% +$25.4K ﹤0.01% 2553
2022
Q2
$60K Buy
+13,340
New +$80.8K ﹤0.01% 2371

Other funds holding TNGX

Mirae Asset Global Investments's TNGX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Tango Therapeutics (TNGX) stake by 7.9% in Q2 2026, selling an estimated $13.7K and leaving 6,469 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

Mirae Asset Global Investments first reported a position in TNGX in Q2 2022 and has held it in 17 quarters since. The position peaked at $241K in Q3 2023. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Mirae Asset Global Investments held 6,469 shares of Tango Therapeutics worth $202K as of Q2 2026.
  • Mirae Asset Global Investments sold 556 Tango Therapeutics shares in Q2 2026, an estimated $13.7K.
  • Tango Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1115 holding.
  • Mirae Asset Global Investments first reported a position in Tango Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Tango Therapeutics position peaked at $241K in Q3 2023.
  • 24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.